We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




CACLP 2025 New Date and Venue Announced

By LabMedica International staff writers
Posted on 16 Oct 2024

The 22nd China International In Vitro Diagnostic Expo, organized by the China Association of Clinical Laboratory Practice Expo (CACLP, Shanghai, China), is set to take place from March 21 to 24, 2025, in Hangzhou, China. More...

Following the impressive numbers recorded by CACLP 2024, the upcoming event will return to provide global participants with a convenient and enriching experience at the newly inaugurated Hangzhou Grand Convention & Exhibition Center.

Situated in the economically dynamic Yangtze River Delta, Hangzhou boasts convenient transportation, advanced innovation, and a wealth of natural and cultural resources. This charming city creates an ideal environment for the in vitro diagnostic (IVD) industry. Hangzhou has 6,626 medical and healthcare institutions, which include 414 hospitals and 27 top-tier (Grade A, Level 3) hospitals. Moreover, Hangzhou has established China’s first dedicated IVD industry promotion institute to support local industry development. With China’s favorable visa-free policy, international participants will find it easier than ever to attend and explore an optimal setting for collaboration, networking, and the latest market trends and innovations.

CACLP 2024 was a remarkable success, showcasing a wide range of products and technologies from participants. The event, which took place in March 2024, attracted 1,346 exhibitors and 42,751 visitors from China and 40 other countries, all gathered in a vast area of 130,000 square meters. A series of academic activities featured 125 scientific lectures presented by 315 academic speakers, drawing over 5,000 delegates. These activities received 462,150 online views via CACLP's WeChat channels and app.

Following the success of CACLP 2024, numerous professionals across the IVD industry are expected to participate in the concurrent academic activities during CACLP 2025. These include the 10th China Experimental Medicine Conference (CEMC) and series sessions, as well as the 12th China IVD Industry Development Conference (CIIDC) and series forums. These activities will encompass in-depth discussions on current hot topics in laboratory medicine and IVD, with renowned experts and scholars presenting cutting-edge research findings, while industry leaders share valuable experiences.

Related Links:
CACLP


Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
UHF RFID Tag & Inlay
AD-327 U9 ETSI Pure 95
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Schematic overview of the deep learning-based circulating exosome analysis for lung cancer detection (Photo courtesy of Chuan Xu, Cheng Jiang)

Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer

Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more

Pathology

view channel
Image: The Aiforia Breast Cancer Grading AI solution is CE-IVD marked (Photo courtesy of Aiforia Technologies)

Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy

Labs that use traditional image analysis methods often suffer from bottlenecks and delays. By digitizing their pathology practices, labs can streamline their work, allowing them to take on larger caseloads... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.